Carregant...
Third‐line systemic treatment for non‐small cell lung cancer
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: In patients with advanced (Stage IIIB and IV) NSCLC with EGFR wild‐type, unknown status of EGFR, or with EGFR activating mutations (Mountain 1997), to assess in terms of OS and PFS the clinical efficacy of third‐...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491211/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011291 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|